Every patient deserves the best therapy.

Cannovum AG is the first German cannabis company listed on the stock exchange. We are a wholesaler, importer and manufacturer of cannabis-based medicines and provide patients in Germany with medical cannabis.

About Cannovum

Live available inventory

Easily check product availability and price.


Pharmacy Workshops

Secure a free, customized workshop now. Online or in your pharmacy.

Customer and product service

Your advantages

Free Shipping

No postage costs for you. Our delivery is free of charge, with no minimum order value.

Next Day Delivery

We will deliver your goods directly on the next working day if we receive your order by 12:30 pm.

Free return

You can easily return unopened Cannovum and OMC products free of charge. We will refund the full amount.

Free Workshop & Consultation

We're offering you and your team free medical education and free consultation


Patients first

The well-being of patients is our highest priority. We aim to facilitate the development of a regulated cannabis market in Europe to help patients obtain the best possible therapy.


Safety and Quality

Safety and quality are the most important factors for us. Our cannabis is imported from GMP-certified producers, who adhere to the highest standards. Every step of our supply chain from the cultivation to the distribution is regulated and controlled.


Cannabis for Europe

Although the beneficial medical properties of cannabis are increasingly established, developments aimed at leveraging these benefits have been slow in Europe. Cannovum clearly focuses on the European market, pioneering our cannabis revolution.

For pharmacies

Our Onlineshop

Pharmacists can easily register with our online shop to place orders. If you have any questions about our products and the associated service, please contact our trained service staff.

Sign up
Screenshot of Cannovum's Online Shop

Our partners

Partner BPCPartner Hanfverband

Latest News

October 19, 2022

Cannovum AG welcomes concrete steps towards legalization of cannabis

Cannovum AG, one of the market leaders in the medical cannabis market, welcomes progress on the legalization of cannabis.

October 10, 2022

Joint research project with Macromedia University on the future of investor communication

Cannovum AG launches the first research project on the future of investor communication with the renowned Macromedia University.

September 7, 2022

Cannovum AG Record sales and new customers in the first half of 2022

Cannovum AG significantly increased both sales and customers in its medical cannabis business in H1 2022.

For investors

If you would like to invest in Cannovum feel free to check and contact us in our investor relations page.

Investor relations

Cannovum Newsletter

Get the latest information and insights:

Successfully subscribed
Something went wrong while submitting the form.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.